vs

Side-by-side financial comparison of Ouster, Inc. (OUST) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $40.7M, roughly 1.5× PETMED EXPRESS INC). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs -23.3%). PETMED EXPRESS INC produced more free cash flow last quarter ($-9.2M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs -20.9%).

Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

OUST vs PETS — Head-to-Head

Bigger by revenue
OUST
OUST
1.5× larger
OUST
$62.2M
$40.7M
PETS
Growing faster (revenue YoY)
OUST
OUST
+129.9% gap
OUST
106.6%
-23.3%
PETS
More free cash flow
PETS
PETS
$27.9M more FCF
PETS
$-9.2M
$-37.2M
OUST
Faster 2-yr revenue CAGR
OUST
OUST
Annualised
OUST
54.8%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
OUST
OUST
PETS
PETS
Revenue
$62.2M
$40.7M
Net Profit
$-10.6M
Gross Margin
60.2%
23.3%
Operating Margin
1.5%
-25.7%
Net Margin
-26.0%
Revenue YoY
106.6%
-23.3%
Net Profit YoY
-1392.6%
EPS (diluted)
$0.10
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OUST
OUST
PETS
PETS
Q4 25
$62.2M
$40.7M
Q3 25
$39.5M
$44.4M
Q2 25
$35.0M
$51.2M
Q1 25
$32.6M
$50.8M
Q4 24
$30.1M
$52.0M
Q3 24
$28.1M
$58.0M
Q2 24
$27.0M
$66.2M
Q1 24
$25.9M
$65.1M
Net Profit
OUST
OUST
PETS
PETS
Q4 25
$-10.6M
Q3 25
$-21.7M
$-8.5M
Q2 25
$-20.6M
$-34.2M
Q1 25
$-22.0M
$-11.6M
Q4 24
$-707.0K
Q3 24
$-25.6M
$2.3M
Q2 24
$-23.9M
$3.8M
Q1 24
$-23.8M
$-5.0M
Gross Margin
OUST
OUST
PETS
PETS
Q4 25
60.2%
23.3%
Q3 25
42.1%
28.0%
Q2 25
45.2%
28.1%
Q1 25
41.3%
29.9%
Q4 24
43.8%
31.0%
Q3 24
38.3%
32.3%
Q2 24
33.7%
28.8%
Q1 24
28.6%
29.3%
Operating Margin
OUST
OUST
PETS
PETS
Q4 25
1.5%
-25.7%
Q3 25
-61.4%
-18.9%
Q2 25
-76.5%
-66.7%
Q1 25
-73.0%
-11.9%
Q4 24
-85.1%
-0.9%
Q3 24
-98.0%
1.0%
Q2 24
-93.6%
6.6%
Q1 24
-99.5%
-5.9%
Net Margin
OUST
OUST
PETS
PETS
Q4 25
-26.0%
Q3 25
-55.0%
-19.2%
Q2 25
-58.8%
-66.7%
Q1 25
-67.5%
-22.9%
Q4 24
-1.4%
Q3 24
-91.1%
4.0%
Q2 24
-88.4%
5.7%
Q1 24
-91.9%
-7.7%
EPS (diluted)
OUST
OUST
PETS
PETS
Q4 25
$0.10
$-0.50
Q3 25
$-0.37
$-0.41
Q2 25
$-0.38
$-1.65
Q1 25
$-0.42
$-0.56
Q4 24
$-0.46
$-0.03
Q3 24
$-0.54
$0.11
Q2 24
$-0.53
$0.18
Q1 24
$-0.55
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OUST
OUST
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$208.6M
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$261.7M
$32.8M
Total Assets
$349.5M
$88.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OUST
OUST
PETS
PETS
Q4 25
$208.6M
$26.9M
Q3 25
$244.5M
$36.1M
Q2 25
$226.5M
$41.1M
Q1 25
$168.2M
$54.7M
Q4 24
$172.0M
$50.1M
Q3 24
$151.4M
$52.0M
Q2 24
$184.2M
$46.0M
Q1 24
$187.8M
$55.3M
Stockholders' Equity
OUST
OUST
PETS
PETS
Q4 25
$261.7M
$32.8M
Q3 25
$247.4M
$43.1M
Q2 25
$221.0M
$51.5M
Q1 25
$167.9M
$85.1M
Q4 24
$180.9M
$96.2M
Q3 24
$171.7M
$96.4M
Q2 24
$170.6M
$93.5M
Q1 24
$167.2M
$96.7M
Total Assets
OUST
OUST
PETS
PETS
Q4 25
$349.5M
$88.0M
Q3 25
$353.8M
$100.3M
Q2 25
$321.8M
$109.8M
Q1 25
$268.6M
$148.7M
Q4 24
$276.1M
$144.8M
Q3 24
$255.2M
$146.0M
Q2 24
$309.9M
$152.7M
Q1 24
$317.7M
$169.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OUST
OUST
PETS
PETS
Operating Cash FlowLast quarter
$-15.4M
$-9.2M
Free Cash FlowOCF − Capex
$-37.2M
$-9.2M
FCF MarginFCF / Revenue
-59.8%
-22.7%
Capex IntensityCapex / Revenue
35.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-64.8M
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OUST
OUST
PETS
PETS
Q4 25
$-15.4M
$-9.2M
Q3 25
$-18.3M
$-2.2M
Q2 25
$-1.3M
$-12.3M
Q1 25
$-4.9M
$7.0M
Q4 24
$-2.6M
$-1.2M
Q3 24
$-3.8M
$7.4M
Q2 24
$-21.6M
$-8.5M
Q1 24
$-5.7M
$7.1M
Free Cash Flow
OUST
OUST
PETS
PETS
Q4 25
$-37.2M
$-9.2M
Q3 25
$-20.0M
$-4.8M
Q2 25
$-2.2M
$-13.6M
Q1 25
$-5.4M
$4.6M
Q4 24
$-4.0M
$-1.9M
Q3 24
$-4.3M
$6.1M
Q2 24
$-22.0M
$-9.2M
Q1 24
$-7.1M
$5.9M
FCF Margin
OUST
OUST
PETS
PETS
Q4 25
-59.8%
-22.7%
Q3 25
-50.7%
-10.8%
Q2 25
-6.3%
-26.5%
Q1 25
-16.6%
9.1%
Q4 24
-13.3%
-3.7%
Q3 24
-15.4%
10.6%
Q2 24
-81.5%
-13.9%
Q1 24
-27.4%
9.0%
Capex Intensity
OUST
OUST
PETS
PETS
Q4 25
35.0%
0.1%
Q3 25
4.3%
5.9%
Q2 25
2.5%
2.5%
Q1 25
1.7%
4.7%
Q4 24
4.8%
1.5%
Q3 24
2.0%
2.2%
Q2 24
1.3%
1.0%
Q1 24
5.3%
1.9%
Cash Conversion
OUST
OUST
PETS
PETS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OUST
OUST

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons